Insider · CIK 0001468308

Andrade Robert

Reports to the SEC for 1 company · RESEARCH TRIANGLE PARK, NC

sec.gov

Transactions

Companies

Filings

CIK

0001468308

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-12	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+3,846 sh	$5.53	+$21.3K	246,855
2026-09-30	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,703 sh	—	—	243,009
2026-08-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,703 sh	—	—	241,306
2026-08-28	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−21.9K sh	—	—	779,330
2026-08-28	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+21.9K sh	$5.10	+$112K	239,603
2026-08-27	FENCFENNEC PHARMACEUTICALS INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−75K sh	$11.78	−$884K	217,675
2026-07-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,703 sh	—	—	292,675
2026-06-30	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,703 sh	—	—	290,972
2026-05-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,703 sh	—	—	289,269
2026-04-30	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,703 sh	—	—	287,566
2026-03-31	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+14.7K sh	—	—	271,380
2026-03-31	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsA Award	CHIEF FINANCIAL OFFICER	AAward	+120K sh	$5.77	+$692K	921,045
2026-03-31	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,213 sh	—	—	273,593
2026-03-28	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+12.3K sh	—	—	285,863
2026-03-26	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−13.1K sh	$5.10	−$66.7K	801,045
2026-03-26	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+13.1K sh	$5.10	+$66.7K	256,656
2026-02-28	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,191 sh	—	—	243,584
2026-02-18	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,450 sh	$4.08	−$9,996	814,117
2026-02-18	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+27.3K sh	—	—	242,393
2026-02-18	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,450 sh	$4.08	+$9,996	215,108
2026-01-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,558 sh	—	—	212,658
2026-01-23	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10K sh	$2.45	+$24.5K	211,100
2026-01-23	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10K sh	$2.45	−$24.5K	816,567
2026-01-15	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10K sh	$2.45	+$24.5K	201,100
2026-01-15	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10K sh	$2.45	−$24.5K	826,567
2026-01-07	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−14.2K sh	$2.45	−$34.8K	836,567
2026-01-07	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+14.2K sh	$2.45	+$34.8K	191,100
2025-12-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,382 sh	—	—	176,916
2025-12-01	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+2,430 sh	—	—	175,534
2025-10-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+2,430 sh	—	—	173,104
2025-09-30	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+2,430 sh	—	—	170,674
2025-08-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+2,431 sh	—	—	168,244
2025-07-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+2,431 sh	—	—	165,813
2025-06-30	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+2,431 sh	—	—	163,382
2025-05-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+2,431 sh	—	—	160,951
2025-05-22	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+8,220 sh	$5.10	+$41.9K	158,520
2025-05-22	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−8,220 sh	$5.10	−$41.9K	850,751
2025-05-16	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+16.7K sh	—	—	150,300
2025-04-30	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,042 sh	—	—	133,633
2025-03-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,042 sh	—	—	132,591
2025-03-28	FENCFENNEC PHARMACEUTICALS INC. · Restricted Share UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+75K sh	—	—	827,722
2025-03-28	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsA Award	CHIEF FINANCIAL OFFICER	AAward	+50K sh	—	—	877,722
2025-02-28	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,042 sh	—	—	131,549
2025-01-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,042 sh	—	—	130,507
2024-12-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,042 sh	—	—	129,465
2024-12-02	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,042 sh	—	—	128,423
2024-11-18	FENCFENNEC PHARMACEUTICALS INC. · Stock OptionsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−15.8K sh	$2.45	−$38.7K	689,184
2024-11-18	FENCFENNEC PHARMACEUTICALS INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+15.8K sh	$2.45	+$38.7K	127,381
2024-10-31	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,042 sh	—	—	111,565
2024-09-30	FENCFENNEC PHARMACEUTICALS INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+1,042 sh	—	—	110,523

Recent filings

Accepted (ET)
Oct 134
Andrade Robert0001468308-26-000034
SEC(opens sec.gov)
Oct 14
Andrade Robert0001468308-26-000032
SEC(opens sec.gov)
Aug 314
Andrade Robert0001468308-26-000030
SEC(opens sec.gov)
Aug 284
Andrade Robert0001468308-26-000028
SEC(opens sec.gov)
Aug 34
Andrade Robert0001468308-26-000026
SEC(opens sec.gov)
Jul 14
Andrade Robert0001468308-26-000024
SEC(opens sec.gov)
Jun 14
Andrade Robert0001468308-26-000022
SEC(opens sec.gov)
May 14
Andrade Robert0001468308-26-000020
SEC(opens sec.gov)
Apr 24
Andrade Robert0001468308-26-000018
SEC(opens sec.gov)
Mar 264
Andrade Robert0001468308-26-000016
SEC(opens sec.gov)
Mar 34
Andrade Robert0001468308-26-000014
SEC(opens sec.gov)
Feb 194
Andrade Robert0001468308-26-000012
SEC(opens sec.gov)

Companies

FENNEC PHARMACEUTICALS INC.CHIEF FINANCIAL OFFICERFENC

Address

C/O FENNEC PHARMACEUTICALS, INC. PO BOX 13628, 68 TW ALEXANDER DRIVE

RESEARCH TRIANGLE PARK, NC, 27709